iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench
30 Oct 2012

iCell Neurons derived from induced pluripotent stem cells (iPSCs) overcome existing models’ limitations in functionality, purity and reproducibility and offer a virtually unlimited supply of well-characterized cells for drug efficacy screening and safety testing. Importantly, using the iPSC technology to produce neurons enable more biologically relevant disease modeling, improved drug screening strategies, and forward movement toward personalized medicine.

Cellular Dynamics International



Show    per page
1 of 9 Page     1 2 3  ... Next 
Issues of Color in Histology in Medicine20 Nov 2014Read
Instrument performance verification in laser diffraction11 Nov 2014Read
From Daltons to Megadaltons on a Single Mass Spectrometry Platform: UHR-qTOF for Biopharmaceuticals Analysis11 Nov 2014Read
Powering power plants with online particle size analysis11 Nov 2014Read
How to characterize and optimize inkjet inks - Part 111 Nov 2014Read
How to characterize and optimize inkjet inks Part 211 Nov 2014Read
Pharmaceuticals - When size is not enough11 Nov 2014Read
Exploring the role of SEC-MALS in protein and polymer characterization11 Nov 2014Read
Clinical Research of Complex Congenital Brain Malformations by Combined Neuroimaging and Massively Parallel Sequencing Using the TruSight One Sequencing Panel6 Nov 2014Read
Increasing Efficiency of Method Validation with Waters Empower 3 Method Validation Manager (MVM)4 Nov 2014Read